About 200 reports

Non-opioid Pain Treatment: Global Markets to 2022 Chapter ##: Introduction ## Study Goals and Objectives ## Reasons for Doing This Study ## Scope of Report ## Information Sources ## Methodology ## Geographic Breakdown ## Analyst’s Credentials ## Related B

  • Analgesic
  • Opioid
  • Therapy
  • World
  • Market Shares

Non-opioid Pain Patch Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024 ##.

  • Opioid
  • Pharmaceutical
  • Therapy
  • World
  • Forecast
  • Preference for Oral Drugs
  • 06. Introduction

About Opioid-induced Constipation Opioids are administered to the patients with acute and non-cancer chronic pain. They have several adverse gastrointestinal effects, one of which is opioid-induced constipation. The opioid analgesics produce analgesia by the activation of the mu receptors found in the CNS and PNS. These drugs affect the...

  • Opioid
  • AstraZeneca PLC
  • Sucampo Pharmaceuticals, Inc.
  • Takeda Pharmaceutical Company Limited
  • Valeant Pharmaceuticals International, Inc.
  • 4.3.1 Opioid Consumption
  • NUMBER OF CHRONIC OPIOID USERS IN THE UK, 2001-2017

Opportunity Analyzer: Opioid-Induced Constipation - Opportunity Analysis and Forecasts to 2019 Summary The Opioid-Induced Constipation (OIC) is a new and rapidly establishing market currently dominated by OTC laxatives set to undergo substantial growth between 2014 and 2019. The main drivers of growth will be an...

  • Opioid
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Progenics Pharmaceuticals, Inc.
  • Salix Pharmaceuticals, Ltd.

Global Market Study on Opioids: Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period ##.

  • Opioid
  • Therapy
  • APAC
  • World
  • Market Size

Opioid Receptor Antagonists- Pipeline Insight, 2018 Executive Summary Overview Opioids Types of Opioid Receptors Opioid Receptor Antagonists in Dermatology Opioid Receptor Antagonists in Gastrointestinal Diseases Opioid Receptor Antagonists in Ce

  • Opioid
  • Therapy
  • ADVICE FOR THE TECHNOLOGY BUYER
  • Data Access and Sharing

IDC ANALYZE THE FUTURE IDC PERSPECTIVE Adelaide O' Brien EXECUTIVE SNAPSHOT FIGURE ## Addiction Prevention and Monitoring: Leveraging DX to Tackle the Opioid Epidemic in Kentucky Executive Snapshot: Addiction Prevention and Monitoring - Leveraging DX to Tackle the

  • Healthcare
  • Information Technology
  • Opioid
  • Therapy
  • United States

One of the major determinants is the growing geriatric population with clinically demonstrated susceptibility to terminal conditions, such as rheumatoid arthritis, is positively impacting this vertical.

  • Opioid
  • Therapy
  • North America
  • United States
  • Forecast
  • OPIOID PRESCRIPTIONS
  • COMMONLY PRESCRIBED OPIOID ANALGESICS STRONG OPIOID ANALGESICS

Abstract Pain is defined as an unpleasant sensory and emotional experience associated with actual or potential tissue damage. At some point, everyone experiences pain. Pain may be described according to severity (mild, moderate, severe), duration (acute or chronic) or type (nociceptive, inflammatory, neuropathic). Mild-to-moderate...

  • Opioid
  • United States
  • Actavis plc
  • Bedrocan Canada Inc.
  • Medical Marijuana, Inc.
  • 3. Opioid Dependence Market
  • 1.5 OPIOIDS OVERVIEW

Pain is defined as an unpleasant feeling brought on by a noxious stimuli or injury. The expression of pain can drive someone to stay away from harmful situations, defend injured tissues and avoid similar situations in future. Usually pain is classified as either acute or chronic, and can also be classified into mild, moderate and severe on...

  • Opioid
  • United States
  • Egalet Corporation
  • Pfizer Inc.
  • Purdue Pharma L.P.

Scope Dosage and treatment regimes for major opioids used in pain management - - Which opioids are used for opioid-naïve patients and for patients that experience continuous pain but respond well to opioids?

  • Opioid
  • Therapy
  • Germany
  • Japan
  • United States
  • Opioids
  • Opioids

About Cancer Pain Therapeutics Cancer pain can be acute or chronic, depending on its stages and types. Cancer pain is caused by the tumor pressing against bones, nerves, or other organs in an individual's body. Pain control is imperative not only for people who have advanced cancer but also for those whose condition remains stable for...

  • Opioid
  • Market Size
  • BioDelivery Sciences International, Inc.
  • ProStrakan Group plc
  • Teva Pharmaceuticals Ltd.
  • 3.1 Opioid Sales in US Chronic Pain Market: Sizing & Growth
  • 3.2 Opioid Sales in US Chronic Pain Market - Forecast: Sizing &

Scope of the Report The report titled “The US Chronic Pain Therapy Market: Trends & Opportunities (2014-2019)” provides an in-depth analysis of the United States chronic pain therapy market (including medication, surgeries and therapies) with detailed analysis of market sizing and growth and market share of the various drugs...

  • Opioid
  • United States
  • Egalet Corporation
  • Pfizer Inc.
  • Zogenix, Inc.

Since the availability of ADF opioids have you become more reluctant to prescribe generic opioids which do not have an ADF?

  • Opioid
  • Pharmaceutical
  • Therapy
  • United States

•Moderate to severe chronic pain therapeutics market is the most mature one and the largest opioid market segment, holding nearly x % of the market share.

  • Opioid
  • Therapy
  • United States
  • Demand
  • Market Size

Deciphering the commercial opportunity is one that analysts are yet to agree on fully.

  • Opioid
  • Pharmaceutical
  • United States
  • World
  • Demand
  • Opioid-Induced Constipation (OIC) - Product Development Milestones
  • Opioid-Induced Constipation (OIC) - Dormant Projects

Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2017, provides an overview of the Opioid-Induced Constipation (OIC) (Toxicology) pipeline landscape. Opioids...

  • Gastrointestinal Drug
  • Opioid
  • United States
  • World
  • Product Initiative
  • Mu Type Opioid Receptor Agonist
  • Opium (Opioid) Addiction - Drug Profiles

Opium (Opioid) Addiction - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Opium (Opioid) Addiction - Pipeline Review, H1 2018, provides an overview of the Opium (Opioid) Addiction (Central Nervous System) pipeline landscape. Opioid...

  • Opioid
  • Therapy
  • United States
  • Product Initiative
  • Addex Therapeutics Ltd
  • Opium (Opioid) Addiction - Therapeutics Assessment
  • Opium (Opioid) Addiction - Drug Profiles

Opium (Opioid) Addiction - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Opium (Opioid) Addiction - Pipeline Review, H2 2017, provides an overview of the Opium (Opioid) Addiction (Central Nervous System) pipeline landscape. Opioid Addiction...

  • Opioid
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • Opioid-Induced Constipation (OIC) - Therapeutics Assessment
  • Opioid-Induced Constipation (OIC) - Dormant Projects

Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2018., provides an overview of the Opioid-Induced Constipation (OIC) (Toxicology) pipeline...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Opioid
  • United States
  • Product Initiative

IR opioids- Abuse deterrent potential ##.

  • Analgesic
  • Opioid
  • Therapy
  • United States
  • LATEST CLINICAL TRIALS NEWS ON OPIUM (OPIOID) ADDICTION
  • TOP COMPANIES PARTICIPATING IN OPIUM (OPIOID) ADDICTION THERAPEUTICS CLINICAL TRIALS

Opium (Opioid) Addiction Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Opium (Opioid) Addiction Global Clinical Trials Review, H1, 2018" provides an overview of Opium (Opioid) Addiction clinical trials scenario.This report provides top line data relating to...

  • Clinical Trial
  • Opioid
  • World
  • Product Initiative
  • Indivior PLC
  • TOP COMPANIES PARTICIPATING IN OPIOID-INDUCED CONSTIPATION (OIC) THERAPEUTICS CLINICAL TRIALS
  • Among the European countries, Germany has the highest number of opioid-induced constipation (oic) clinical trials, as of April 2018.

Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H1, 2018" provides an overview of Opioid-Induced Constipation (OIC) clinical trials scenario.This report provides...

  • Clinical Trial
  • Gastrointestinal Drug
  • Opioid
  • World
  • Product Initiative

(USA) ##.

  • Analgesic
  • Opioid
  • Therapy
  • United States
  • Market Shares
  • Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) - Product Development Milestones
  • Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) - Dormant Products

Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) - Pipeline Review, H2 2017 Summary According to the recently published report ’Nociceptin Receptor - Pipeline Review, H2 2017’; Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) pipeline...

  • Analgesic
  • Hospital
  • Hypertension
  • Opioid
  • Therapy

(USA) ##.

  • Opioid
  • China
  • United States
  • Demand
  • Market Shares
  • OPIOID-INDUCED BOWEL DYSFUNCTION (OBD OR OIBD) THERAPEUTICS, GLOBAL, CLINICAL TRIALS IN PROGRESS BY PHASE, 2018*
  • OPIOID-INDUCED BOWEL DYSFUNCTION (OBD OR OIBD) THERAPEUTICS CLINICAL TRIALS, GLOBAL, KEY SPONSORS, 2018*

Opioid-Induced Bowel Dysfunction (OBD or OIBD) Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Opioid-Induced Bowel Dysfunction (OBD or OIBD) Global Clinical Trials Review, H1, 2018" provides an overview of Opioid-Induced Bowel Dysfunction (OBD or OIBD) clinical...

  • Opioid
  • Therapy
  • World
  • Product Initiative
  • GlaxoSmithKline plc
  • Latest Clinical Trials News on Opium (Opioid) Addiction
  • Top Companies Participating in Opium (Opioid) Addiction Therapeutics Clinical Trials

Opium (Opioid) Addiction Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Opium (Opioid) Addiction Global Clinical Trials Review, H2, 2016" provides an overview of Opium (Opioid) Addiction clinical trials scenario. This report provides top line data relating to the clinical trials on...

  • Clinical Trial
  • Opioid
  • Therapy
  • World
  • Product Initiative
  • TOP COMPANIES PARTICIPATING IN OPIOID-INDUCED CONSTIPATION (OIC) THERAPEUTICS CLINICAL TRIALS
  • Clinical Trials by G7 Countries: Proportion of Opioid-Induced Constipation (OIC) to Toxicology Clinical Trials

Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H2, 2016" provides an overview of Opioid-Induced Constipation (OIC) clinical trials scenario. This report provides top line data relating...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Opioid
  • World
  • Product Initiative
  • Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) - Discontinued Products
  • Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) - Product Development Milestones

Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) – Pipeline Review, H1 2018 Summary Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) – Nociceptin receptor also known as the nociceptin or orphanin FQ receptor or...

  • Opioid
  • Therapy
  • United States
  • World
  • Product Initiative